March 17, 2025

Do Congenital Heart Defects Affect Cancer Risk in Newborns and Their Mothers?

A study published in the American Heart Association's journal Circulation explored whether babies born with a congenital heart defects and their mothers may experience an elevated risk of cancer.   

The ASCO Post

March 17, 2025

Advances in Endometrial Cancer Detection, Treatment

Two novel studies may provide insights into advancements in the detection and treatment of endometrial cancer, according to new findings presented at the Society of Gynecologic Oncology (SGO) 2025 Ann...

The ASCO Post

March 17, 2025

MRD and Adjuvant Osimertinib in Resected EGFR-Mutated Stage IB–IIIA NSCLC

In a study published in Nature Medicine, Herbst et al evaluated whether molecular residual disease (MRD) could be used to improve outcomes by identifying patients with EGFR-mutated NSCLC who might ben...

The ASCO Post

March 17, 2025

Atezolizumab Plus Carboplatin/Paclitaxel in Advanced Thymic Carcinoma

In a Japanese phase II trial (MARBLE) reported in The Lancet Oncology, Shukuya et al evaluated a regimen of atezolizumab plus carboplatin/paclitaxel in patients with recurrent or metastatic thymic car...

The ASCO Post

March 17, 2025

BVAC-C Plus Durvalumab May Show Potential in Patients With Recurrent Cervical Cancer

Researchers have explored whether a novel treatment approach may improve outcomes in patients with recurrent or metastatic cervical cancer, according to new findings presented at the Society of Gyneco...

The ASCO Post

March 14, 2025

Genomic Study Reveals Similarities, Differences in Ovarian Cancer Mutations Among Black, White Patients

Investigators may have uncovered nearly identical mutations to previously examined patient populations and several notable differences that may be clinically relevant among Black patients with ovarian...

The ASCO Post

March 14, 2025

Neoadjuvant Combination Immunotherapy for Head and Neck Cancer

A combination of two immunotherapies may improve treatment response among patients with head and neck squamous cell carcinomas compared with just one immunotherapy drug.

The ASCO Post

March 14, 2025

Cervical Precancer Incidence Decreases as HPV Vaccination Rates Rise

Recent findings from HPV-IMPACT project revealed decreased incidences of cervical intraepithelial neoplasia (CIN)2+ and CIN3+ lesions among young women.

The ASCO Post

March 14, 2025

Experimental Regimen Demonstrates Benefit in BRAF V600E–Mutant Metastatic Colorectal Cancer

The BRAF inhibitor encorafenib plus the monoclonal antibody cetuximab combined with mFOLFOX (modified folinic acid, fluorouracil, and oxaliplatin) significantly improved overall response in BRAF V600E...

The ASCO Post